乳腺癌的分子研究与治疗
Molecular Research and Treatment of Breast Cancer.
机构信息
Intercollegiate Faculty of Biotechnology, University of Gdansk, Abrahama 58, 80-307 Gdansk, Poland.
出版信息
Int J Mol Sci. 2022 Aug 25;23(17):9617. doi: 10.3390/ijms23179617.
Abstract
Breast cancer is the leading cause of cancer-related deaths in the female population [...].
摘要
乳腺癌是女性癌症相关死亡的主要原因[... ]。
相似文献
1
Molecular Research and Treatment of Breast Cancer.乳腺癌的分子研究与治疗
Int J Mol Sci. 2022 Aug 25;23(17):9617. doi: 10.3390/ijms23179617.
2
Breast cancer in Africa: prevalence, treatment options, herbal medicines, and socioeconomic determinants.非洲的乳腺癌：患病率、治疗选择、草药和社会经济决定因素。
Breast Cancer Res Treat. 2017 Nov;166(2):351-365. doi: 10.1007/s10549-017-4408-0. Epub 2017 Aug 4.
3
Breast cancer in Russia.俄罗斯的乳腺癌
Breast Cancer. 2004;11(1):7-9. doi: 10.1007/BF02967993.
4
[Breast cancer].[乳腺癌]
Ned Tijdschr Tandheelkd. 1998 Sep;105(9):330-1.
5
[Third revision of the National Consensus on Diagnosis and Treatment of Breast Cancer (third of three parts)].《乳腺癌诊疗全国共识（第三版）（三部分之三）》
Ginecol Obstet Mex. 2010 Mar;78(3):199-212.
6
Breast cancer: presentation, investigation and management.乳腺癌：临床表现、检查及处理。
Br J Hosp Med (Lond). 2022 Feb 2;83(2):1-7. doi: 10.12968/hmed.2021.0459. Epub 2022 Feb 7.
7
Breast cancer symposium highlights risk, recurrence, and research trials.乳腺癌研讨会聚焦风险、复发及研究试验。
JAMA. 2012 Jan 25;307(4):348-50. doi: 10.1001/jama.2012.30.
8
Breast cancer proteomics: clinical perspectives.乳腺癌蛋白质组学：临床展望。
Expert Opin Biol Ther. 2007 Feb;7(2):209-19. doi: 10.1517/14712598.7.2.209.
9
Recent advances in breast cancer biology.乳腺癌生物学的最新进展。
Curr Opin Oncol. 1999 Nov;11(6):429-34. doi: 10.1097/00001622-199911000-00002.
10
Tumours: Less lactation may explain cancer rise.肿瘤：哺乳减少或可解释癌症发病率上升的原因。
Nature. 2012 Jun 27;486(7404):473. doi: 10.1038/486473c.
引用本文的文献
1
Synergistic Antitumor Effects of Ivermectin and Metformin in Canine Breast Cancer via PI3K/AKT/mTOR Pathway Inhibition.伊维菌素和二甲双胍通过抑制PI3K/AKT/mTOR信号通路对犬乳腺癌的协同抗肿瘤作用
Curr Issues Mol Biol. 2025 May 29;47(6):403. doi: 10.3390/cimb47060403.
2
Lactate and lactylation in breast cancer: current understanding and therapeutic opportunities.乳腺癌中的乳酸与乳酰化：当前认知与治疗机遇
Cancer Biol Med. 2025 Jul 16;22(7):789-805. doi: 10.20892/j.issn.2095-3941.2025.0173.
3
Integrative proteomics and metabolomics analyses reveals the regulation of autophagy and ferroptosis by RAB10 through Slc37a2/mTOR pathway in breast cancer.整合蛋白质组学和代谢组学分析揭示了RAB10通过Slc37a2/mTOR途径在乳腺癌中对自噬和铁死亡的调控。
Cell Mol Life Sci. 2025 Jul 14;82(1):275. doi: 10.1007/s00018-025-05788-5.
4
From Microbial Homeostasis to Systemic Pathogenesis: A Narrative Review on Gut Flora's Role in Neuropsychiatric, Metabolic, and Cancer Disorders.从微生物稳态到全身发病机制：关于肠道菌群在神经精神、代谢和癌症疾病中作用的叙述性综述
J Inflamm Res. 2025 Jul 5;18:8851-8873. doi: 10.2147/JIR.S531671. eCollection 2025.
5
Multi-omics analysis of the effects of pla2g4a on the prognosis of various cancers and its experimental validation in breast cancer cell lines.磷脂酶A2γ4a（PLA2G4A）对各种癌症预后影响的多组学分析及其在乳腺癌细胞系中的实验验证
Discov Oncol. 2025 Jul 7;16(1):1278. doi: 10.1007/s12672-025-03118-6.
6
Ultrasonic Parameters as Biomarkers for Tumor Staging and Aggressiveness in Breast Cancer: Correlation with GP73 and miR-27a.超声参数作为乳腺癌肿瘤分期和侵袭性的生物标志物：与GP73和miR-27a的相关性
Int J Gen Med. 2025 Jun 21;18:3313-3321. doi: 10.2147/IJGM.S521769. eCollection 2025.
7
ALKBH5 Promotes Breast Cancer Stemness Through Regulating Wnt/β-Catenin Signaling.ALKBH5通过调控Wnt/β-连环蛋白信号通路促进乳腺癌干性。
Breast Cancer (Dove Med Press). 2025 Jun 6;17:471-482. doi: 10.2147/BCTT.S520532. eCollection 2025.
8
Analysis of Serum Soluble Endoglin and s-CD105 Levels in Relation to Postoperative Recurrence and Metastasis in Breast Cancer Patients Treated with Modified Radical Mastectomy.改良根治术治疗的乳腺癌患者血清可溶性内皮糖蛋白和可溶性CD105水平与术后复发及转移的关系分析
Int J Womens Health. 2025 May 31;17:1597-1604. doi: 10.2147/IJWH.S515952. eCollection 2025.
9
The Role of PANoptosis-Related Genes in Predicting Breast Cancer Survival and Immune Prospect.细胞焦亡相关基因在预测乳腺癌生存及免疫前景中的作用
Biomed Res Int. 2025 May 28;2025:3423698. doi: 10.1155/bmri/3423698. eCollection 2025.
10
Integrating Machine Learning and Bulk and Single-Cell RNA Sequencing to Decipher Diverse Cell Death Patterns for Predicting the Prognosis of Neoadjuvant Chemotherapy in Breast Cancer.整合机器学习与批量及单细胞RNA测序以解析多种细胞死亡模式用于预测乳腺癌新辅助化疗的预后
Int J Mol Sci. 2025 Apr 13;26(8):3682. doi: 10.3390/ijms26083682.
本文引用的文献
1
A Novel CDK4/6 and PARP Dual Inhibitor ZC-22 Effectively Suppresses Tumor Growth and Improves the Response to Cisplatin Treatment in Breast and Ovarian Cancer.一种新型 CDK4/6 和 PARP 双重抑制剂 ZC-22 有效抑制乳腺癌和卵巢癌的肿瘤生长并提高顺铂治疗的反应。
Int J Mol Sci. 2022 Mar 7;23(5):2892. doi: 10.3390/ijms23052892.
2
Primaquine Inhibits the Endosomal Trafficking and Nuclear Localization of EGFR and Induces the Apoptosis of Breast Cancer Cells by Nuclear EGFR/Stat3-Mediated c-Myc Downregulation.磷酸氯喹通过抑制 EGFR 的内体运输和核定位并通过核 EGFR/Stat3 介导的 c-Myc 下调诱导乳腺癌细胞凋亡。
Int J Mol Sci. 2021 Nov 30;22(23):12961. doi: 10.3390/ijms222312961.
3
Aptamer-Aptamer Chimera for Targeted Delivery and ATP-Responsive Release of Doxorubicin into Cancer Cells.适体-适体嵌合体用于阿霉素靶向递送至癌细胞和ATP 响应性释放。
Int J Mol Sci. 2021 Nov 30;22(23):12940. doi: 10.3390/ijms222312940.
4
Doxorubicin-Resistant TNBC Cells Exhibit Rapid Growth with Cancer Stem Cell-like Properties and EMT Phenotype, Which Can Be Transferred to Parental Cells through Autocrine Signaling.多柔比星耐药的三阴性乳腺癌细胞表现出具有癌症干细胞样特性和 EMT 表型的快速生长，这种特性和表型可以通过自分泌信号传递给亲本细胞。
Int J Mol Sci. 2021 Nov 18;22(22):12438. doi: 10.3390/ijms222212438.
5
The Presence of Yin-Yang Effects in the Migration Pattern of Staurosporine-Treated Single versus Collective Breast Carcinoma Cells.阿霉素诱导的乳腺癌细胞单克隆和群体迁移模式中的阴阳效应。
Int J Mol Sci. 2021 Nov 4;22(21):11961. doi: 10.3390/ijms222111961.
6
OCT1 Is a Poor Prognostic Factor for Breast Cancer Patients and Promotes Cell Proliferation via Inducing NCAPH.OCT1 是乳腺癌患者的不良预后因素，并通过诱导 NCAPH 促进细胞增殖。
Int J Mol Sci. 2021 Oct 25;22(21):11505. doi: 10.3390/ijms222111505.
7
New Advances in the Research of Resistance to Neoadjuvant Chemotherapy in Breast Cancer.乳腺癌新辅助化疗耐药研究新进展。
Int J Mol Sci. 2021 Sep 6;22(17):9644. doi: 10.3390/ijms22179644.
8
Efficacy and mechanism of the combination of PARP and CDK4/6 inhibitors in the treatment of triple-negative breast cancer.聚腺苷二磷酸核糖聚合酶（PARP）与细胞周期蛋白依赖性激酶 4/6（CDK4/6）抑制剂联合治疗三阴性乳腺癌的疗效及机制。
J Exp Clin Cancer Res. 2021 Apr 8;40(1):122. doi: 10.1186/s13046-021-01930-w.
9
Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression.以乳腺癌为例，探讨肿瘤异质性和肿瘤细胞可塑性在恶性进展过程中的作用。
Br J Cancer. 2021 Jul;125(2):164-175. doi: 10.1038/s41416-021-01328-7. Epub 2021 Apr 6.
10
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020：全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
Zotero 插件